TREM2 and Alzheimer disease: AD patients that also harbor the TREM2-R47H variant display even higher levels of total tau and P-Tau Thr181 in CSF compared to non-carriers [286,287,288], which is indicative of exacerbated pathogenic tau burden in the brain and neuronal loss [289].